
John Kwon
Examiner (ID: 226, Phone: (571)272-4846 , Office: P/3747 )
| Most Active Art Unit | 3747 |
| Art Unit(s) | 2403, 2605, 3747, 2402, 3745, 3404, 3401, 3754, 3622 |
| Total Applications | 4781 |
| Issued Applications | 4291 |
| Pending Applications | 92 |
| Abandoned Applications | 420 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16877034
[patent_doc_number] => 11027155
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-08
[patent_title] => Method for prevention and treatment of diabetic kidney disease
[patent_app_type] => utility
[patent_app_number] => 16/653665
[patent_app_country] => US
[patent_app_date] => 2019-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 14
[patent_no_of_words] => 5730
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16653665
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/653665 | Method for prevention and treatment of diabetic kidney disease | Oct 14, 2019 | Issued |
Array
(
[id] => 17258445
[patent_doc_number] => 20210371430
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => HETEROCYCLIC AMIDE FOR INHIBITING RIP1 KINASE AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/289642
[patent_app_country] => US
[patent_app_date] => 2019-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15155
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 705
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17289642
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/289642 | Heterocyclic amide for inhibiting RIP1 kinase and uses thereof | Oct 7, 2019 | Issued |
Array
(
[id] => 16567421
[patent_doc_number] => 10892802
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-12
[patent_title] => Metal plating compositions
[patent_app_type] => utility
[patent_app_number] => 16/603319
[patent_app_country] => US
[patent_app_date] => 2019-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 4487
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 202
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16603319
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/603319 | Metal plating compositions | Oct 6, 2019 | Issued |
Array
(
[id] => 16211661
[patent_doc_number] => 20200244651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => NOVEL SALTS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/588207
[patent_app_country] => US
[patent_app_date] => 2019-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25162
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16588207
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/588207 | Salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders | Sep 29, 2019 | Issued |
Array
(
[id] => 16642076
[patent_doc_number] => 10919912
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-16
[patent_title] => Tricyclic heterocycles as BET protein inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/585568
[patent_app_country] => US
[patent_app_date] => 2019-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55253
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 636
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16585568
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/585568 | Tricyclic heterocycles as BET protein inhibitors | Sep 26, 2019 | Issued |
Array
(
[id] => 15768643
[patent_doc_number] => 20200115339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-16
[patent_title] => EFFLUX-PUMP INHIBITORS AND THERAPEUTIC USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/574537
[patent_app_country] => US
[patent_app_date] => 2019-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75337
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -59
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16574537
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/574537 | EFFLUX-PUMP INHIBITORS AND THERAPEUTIC USES THEREOF | Sep 17, 2019 | Abandoned |
Array
(
[id] => 15345165
[patent_doc_number] => 20200010474
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => SUBSTITUTED 4-METHYL-PYRROLO[1,2-A]PYRIMIDINE-8-CARBOXAMIDE COMPOUNDS AND USES THEREOF FOR MODULATING GLUCOCEREBROSIDASE ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 16/572466
[patent_app_country] => US
[patent_app_date] => 2019-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19079
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 250
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16572466
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/572466 | SUBSTITUTED 4-METHYL-PYRROLO[1,2-A]PYRIMIDINE-8-CARBOXAMIDE COMPOUNDS AND USES THEREOF FOR MODULATING GLUCOCEREBROSIDASE ACTIVITY | Sep 15, 2019 | Abandoned |
Array
(
[id] => 19794335
[patent_doc_number] => 12235275
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-25
[patent_title] => Fluorescent substrates for poly(ADP-ribosyl) hydrolases
[patent_app_type] => utility
[patent_app_number] => 17/274395
[patent_app_country] => US
[patent_app_date] => 2019-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 8
[patent_no_of_words] => 20125
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17274395
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/274395 | Fluorescent substrates for poly(ADP-ribosyl) hydrolases | Sep 8, 2019 | Issued |
Array
(
[id] => 18020526
[patent_doc_number] => 20220372025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => METHOD FOR PRODUCING TETRACYCLIC COMPOUND
[patent_app_type] => utility
[patent_app_number] => 17/271437
[patent_app_country] => US
[patent_app_date] => 2019-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10885
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17271437
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/271437 | Method for producing tetracyclic compound | Sep 2, 2019 | Issued |
Array
(
[id] => 15345121
[patent_doc_number] => 20200010452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/553061
[patent_app_country] => US
[patent_app_date] => 2019-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33376
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 533
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16553061
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/553061 | Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof | Aug 26, 2019 | Issued |
Array
(
[id] => 15813943
[patent_doc_number] => 10632128
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-28
[patent_title] => Compounds that inhibit Mcl-1 protein
[patent_app_type] => utility
[patent_app_number] => 16/547747
[patent_app_country] => US
[patent_app_date] => 2019-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 103271
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1361
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16547747
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/547747 | Compounds that inhibit Mcl-1 protein | Aug 21, 2019 | Issued |
Array
(
[id] => 20172953
[patent_doc_number] => 12391685
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-19
[patent_title] => Inhibitors of RNA-guided nuclease target binding and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/269900
[patent_app_country] => US
[patent_app_date] => 2019-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 121
[patent_no_of_words] => 64346
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17269900
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/269900 | Inhibitors of RNA-guided nuclease target binding and uses thereof | Aug 19, 2019 | Issued |
Array
(
[id] => 16198578
[patent_doc_number] => 10723728
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-28
[patent_title] => Prodrugs of Nh-acidic compounds
[patent_app_type] => utility
[patent_app_number] => 16/540802
[patent_app_country] => US
[patent_app_date] => 2019-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 20518
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 277
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16540802
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/540802 | Prodrugs of Nh-acidic compounds | Aug 13, 2019 | Issued |
Array
(
[id] => 15293367
[patent_doc_number] => 20190389819
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => PROCESSES FOR PREPARING OXATHIAZIN-LIKE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/538344
[patent_app_country] => US
[patent_app_date] => 2019-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9523
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16538344
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/538344 | Processes for preparing oxathiazin-like compounds | Aug 11, 2019 | Issued |
Array
(
[id] => 17533568
[patent_doc_number] => 20220112177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => KETOAMIDE COMPOUND AND PREPARATION METHOD, PHARMACEUTICAL COMPOSITION, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/267375
[patent_app_country] => US
[patent_app_date] => 2019-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32766
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 486
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17267375
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/267375 | Ketoamide compound and preparation method, pharmaceutical composition, and use thereof | Aug 8, 2019 | Issued |
| 16/535279 | Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer | Aug 7, 2019 | Abandoned |
Array
(
[id] => 15711023
[patent_doc_number] => 20200102277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-02
[patent_title] => PROCESS METHODS FOR PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/533506
[patent_app_country] => US
[patent_app_date] => 2019-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12177
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16533506
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/533506 | Process methods for phosphatidylinositol 3-kinase inhibitors | Aug 5, 2019 | Issued |
Array
(
[id] => 16483887
[patent_doc_number] => 20200377488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => A NOVEL COMPOUND DERIVED FROM ALLULOSE
[patent_app_type] => utility
[patent_app_number] => 16/491486
[patent_app_country] => US
[patent_app_date] => 2019-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4549
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16491486
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/491486 | Compound derived from allulose | Aug 1, 2019 | Issued |
Array
(
[id] => 16429433
[patent_doc_number] => 10829500
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-10
[patent_title] => Pyridyl-triazabicycles
[patent_app_type] => utility
[patent_app_number] => 16/527307
[patent_app_country] => US
[patent_app_date] => 2019-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10941
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16527307
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/527307 | Pyridyl-triazabicycles | Jul 30, 2019 | Issued |
Array
(
[id] => 15571403
[patent_doc_number] => 10576059
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-03
[patent_title] => Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV
[patent_app_type] => utility
[patent_app_number] => 16/521327
[patent_app_country] => US
[patent_app_date] => 2019-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9794
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16521327
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/521327 | Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV | Jul 23, 2019 | Issued |